Facebook Linkedin Twitter
Inside Precision Medicine Lilly and Confo Ink Deal around Non-Opioid Pain Candidate

Phase I clinical trials (Drug development)

woman holding her wrist pain because using smartphone or computer long time. De Quervain's tenosynovitis, Intersection Symptom, Carpal Tunnel Syndrome or Office syndrome concept. To illustrate tendon damage
News & Features

Lilly and Confo Ink Deal around Non-Opioid Pain Candidate

0
Lymphocytes attacking a cancer cell, illustration
News & Features

Syena Launched by MD Anderson and Replay to Develop TCR NK Cell Therapy

0
Artificial DNA and Intelligence
News & Features

Insilico Medicine’s AI-Designed Fibrosis Drug Passes Phase I Hurdle

0
T Cells Attacking Cancer Cell
News & Features

Gilead to Purchase Remaining Rights to Potential First-in-Class Immunotherapy from Jounce Therapeutics

0
graphic of the number six
News & Features

These Six Biotechs are Winning the Race to Get AI-Designed Drugs to the Clinic

Helen Albert
0
Picture of patient receiving a dancer drug to represent precision cancer therapies
News & Features

Inhibitor of RET Receptor Tyrosine Kinase Shows Promise Against Multiple Cancers

0
Cancer cells on dna stand background. 3d illustration
Molecular Dx

Repare Nets Potential $1.2B Plus Deal with Roche for ATR Inhibitor

0
Targeted cancer therapy
News & Features

Sapience Nets $41M for Peptides Against Hard Targets in Cancer

0
Glioblastoma brain cancer, CT scan
News & Features

FAP-Targeting Imaging Tracker Prepares for Phase 1 Brain Cancer Trial

0
skin allergy
News & Features

Third Harmonic Bio Comes Out of Stealth Mode With $155M Series B Fundraising Round

0
12345Page 3 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine